Medication info
Gladiam Tablet 1 mg (Glymepiride)

Gladiam Tablet 1 mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›1mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Pink oblong tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200500559 · Notified 2005.01.17 · Insurance code 642100070

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medication is administered orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medication There is no exact dose equivalence between this medication and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent to this medication, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medication should be taken into account. 4) Dose adjustment during treatment While taking this medication, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initial successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medication and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used alone, but when blood sugar control is insufficient, it can be combined with other hypoglycemic agents or insulin to enhance therapeutic effect. For instance, when sulfonylureas or metformin used alone are ineffective, this medication can be used in combination to better stabilize blood sugar levels. This allows for improved blood sugar management tailored to each patient's condition through various administration methods.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medication is administered orally once daily. Take this medication before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect at doses above 4 mg, but some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medication There is no exact dose equivalence between this medication and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent to this medication, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medication should be taken into account. 4) Dose adjustment during treatment While taking this medication, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initial successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medication and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Patients who have had an allergic reaction to this medication, its ingredients, or sulfonylureas should not take it. There is no experience in using this medication in patients with severely impaired liver or kidney function, hence switching to insulin therapy is recommended in such cases. It is advisable not to administer this medication to women who are pregnant or likely to become pregnant, as well as those who are breastfeeding. Patients with severe infections, preoperative or postoperative states, or severe trauma should ideally receive insulin therapy, and those with gastrointestinal disorders may be at risk of hypoglycemia due to food absorption issues and should be cautious. During the first week of initial dosing, the risk of hypoglycemia is high, and blood sugar should be closely monitored. Older adults, those with poor nutritional status, patients with irregular eating patterns, alcohol users, and patients with decreased liver or kidney function should be given this medication with increased caution. This medication has a strong effect in lowering blood sugar, so patients should be attentive to symptoms of hypoglycemia, which may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness. If hypoglycemia occurs, sugar-containing foods should be consumed immediately, and it is advisable to carry sugar at all times. Occasionally, blurred vision, digestive disturbances, liver function anomalies, decreased blood cell counts, and allergic reactions may occur; if symptoms arise, consult a doctor immediately. Regular meals and exercise should be maintained while taking this medication, and blood sugar control should be continuously monitored. When combining with other medications, interactions may occur, so all medications being taken should be reported to a physician or pharmacist. Particularly when taken with beta-blockers, antibiotics, anticoagulants, corticosteroids, etc., blood sugar changes should be closely monitored. If pregnant or breastfeeding, it is recommended to use insulin therapy instead of this medication, and breastfeeding may need to be discontinued if necessary. In cases of overdose, severe hypoglycemia may occur, necessitating immediate hospital treatment. The safety and efficacy of this medication have not been established in children, and dosage adjustments should be made in elderly patients considering their kidney function. Finally, this medication should be stored out of reach of children and kept in its original container for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech disturbances, aphasia, visual disturbances, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, skin and mucous membrane syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best kept at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oblong tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.